Rebecca Arend
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer (NCT07772882) | Rebecca Arend | 2026-09-01 |
Track Rebecca Arend automatically
Every clearance here is in the API, with alerts when new ones post.